Margaret Rothman
Overview
Explore the profile of Margaret Rothman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
4095
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Rhee F, Rothman M, Ho K, Fleming S, Wong R, Fossa A, et al.
Patient
. 2015 Mar;
8(2):207-16.
PMID: 25736164
Background: Multicentric Castleman's disease (MCD) is a rare lymphoproliferative disorder driven by dysregulated interleukin-6 production. MCD has a poor prognosis, and treatment is generally noncurative and aimed at symptom relief....
2.
Rothman M, Gnanaskathy A, Wicks P, Papadopoulos E
Value Health
. 2015 Jan;
18(1):1-4.
PMID: 25595228
We report a panel designed to open a dialog between pharmaceutical sponsors, regulatory reviewers, and other stakeholders regarding the use of social media to collect data to support the content...
3.
van Rhee F, Wong R, Munshi N, Rossi J, Ke X, Fossa A, et al.
Lancet Oncol
. 2014 Jul;
15(9):966-74.
PMID: 25042199
Background: Multicentric Castleman's disease is a rare lymphoproliferative disorder driven by dysregulated production of interleukin 6. No randomised trials have been done to establish the best treatment for the disease....
4.
Logothetis C, Basch E, Molina A, Fizazi K, North S, Chi K, et al.
Lancet Oncol
. 2012 Nov;
13(12):1210-7.
PMID: 23142059
Background: Bone metastases are a major cause of morbidity in metastatic castration-resistant prostate cancer. Abiraterone acetate potently disrupts intracrine androgen receptor signalling pathways implicated in the progression of the disease,...
5.
Camilleri M, Rothman M, Ho K, Etropolski M
Am J Gastroenterol
. 2010 Nov;
106(3):497-506.
PMID: 21063394
Objectives: Validated tools to assess opioid-induced constipation (OIC) are needed. The aim of this study was to validate a Bowel Function Diary (BF-Diary) that includes patient-reported outcomes (PROs) associated with...
6.
McMahon C, Althof S, Kaufman J, Buvat J, Levine S, Aquilina J, et al.
J Sex Med
. 2010 Nov;
8(2):524-39.
PMID: 21059176
Introduction: Dapoxetine has been evaluated for the on-demand treatment of premature ejaculation (PE) in five phase 3 studies in various populations worldwide and has recently been approved in several countries....
7.
Morales A, Zargooshi J, Jern P, McCullough A, Hellstrom W, Shamloul R, et al.
J Sex Med
. 2010 May;
7(2 Pt 1):679-89.
PMID: 20492417
No abstract available.
8.
Althof S, Brock G, Rosen R, Rowland D, Aquilina J, Rothman M, et al.
J Sex Med
. 2010 Apr;
7(6):2243-2252.
PMID: 20367770
Introduction: The Clinical Global Impression of Change (CGIC) measures have high utility in clinical practice. However, it is unknown whether the CGIC is valued for assessing premature ejaculation (PE) symptoms...
9.
Patrick D, Burns T, Morosini P, Gagnon D, Rothman M, Adriaenssen I
Clin Ther
. 2010 Mar;
32(2):275-92.
PMID: 20206786
Background: The safety and efficacy of paliperidone extended-release tablets (paliperidone ER) in patients with acute symptoms of schizophrenia have been described in 3 randomized, double-blind, 6-week, placebo-controlled, fixed-dose, Phase III...
10.
McMahon C, Kim S, Park N, Chang C, Rivas D, Tesfaye F, et al.
J Sex Med
. 2009 Nov;
7(1 Pt 1):256-68.
PMID: 19878447
Introduction: Dapoxetine is a short-acting selective serotonin reuptake inhibitor that was recently approved for the on-demand treatment of premature ejaculation (PE). Aim: To evaluate the efficacy and safety of dapoxetine...